Rakuten Investment Management, Inc. Neurocrine Biosciences Inc Transaction History
Rakuten Investment Management, Inc.
- $21.8 Billion
- Q1 2025
A detailed history of Rakuten Investment Management, Inc. transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Rakuten Investment Management, Inc. holds 2,794 shares of NBIX stock, worth $336,034. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,794Holding current value
$336,034% of portfolio
0.0%Shares
5 transactions
Others Institutions Holding NBIX
# of Institutions
651Shares Held
96.5MCall Options Held
702KPut Options Held
553K-
Black Rock Inc. New York, NY14.2MShares$1.71 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.94MShares$1.2 Billion0.02% of portfolio
-
Dodge & Cox San Francisco, CA5.53MShares$666 Million0.37% of portfolio
-
State Street Corp Boston, MA4.86MShares$585 Million0.02% of portfolio
-
Jpmorgan Chase & CO New York, NY2.67MShares$321 Million0.02% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $11.5B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...